ZBIO Bathi mangsa ngarep Zenas Bio

Zenas Biopharma, Inc. - logo grafis emiten ZBIO

High entry barriers and antibody patent protection drive the net revenue forecast for Zenas Biopharma Inc (ZBIO), where represents the current metric. Growth is supported by the development of obexelimab to capture the IgG4-related disease niche. However, a lack of pricing power due to the current trial stage and a reliance on venture capital investments create volatility on the expected profit chart.

ZBIO: Prakiraan bathi perusahaan Zenas Biopharma Inc 04.07.2022 - 18.11.2026

Rincian analitis perusahaan Zenas Biopharma Inc

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:ZBIO, Zenas Biopharma, Inc.
Barang utama Zenas Corp

Zenas Biopharma Inc (ZBIO) is mitigating the risks associated with antibody development for autoimmune diseases through strategic alliances with global pharmaceutical behemoths. By analyzing the company's earnings forecast history, investors can observe a smoothed daily trajectory of expected revenues, which enables an objective assessment of the business's fundamental growth vector and prevents purchasing the asset at a valuation peak during shifts in market conditions.

Perusahaan pesaing

ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (protagonist-inc.com)|Prakiraan bathi perusahaan immunovant.com (IMVT)|KNSA - Bathi sing dikarepake|Grifols SA (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Inc. (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep biocryst.com|Bathi sing dikarepake Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Bathi resik sing dikarepake|TRML: Bathi mangsa ngarep|Bathi forward PGEN|PHAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Nektar Therapeutics Inc (NKTR)|Bathi mangsa ngarep UPB|Bathi mangsa ngarep Immunome, Inc. (IMNM)|Bathi sing dikarepake gossamerbio.com (GOSS)|Bathi sing dikarepake KALV (KalVista Pharmaceuticals)|Proyeksi bathi mangsa ngarep SEPN (Septerna Pharma)|Prakiraan bathi perusahaan Pieris Pharma (PVLA)|Savara Inc - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake RIGL (Rigel Corp)|anaptysbio.com (ANAB) - Bathi sing dikarepake|Astria Therapeutics, Inc. - Penghasilan resik sing dikarepake|ENGN (enGene) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake RAPT Therapeutics Inc. RAPT|Bathi mangsa ngarep JBIO (Aerovate Therapeutics, Inc.)|Bathi resik mangsa ngarep ACRS|Proyeksi bathi mangsa ngarep KYTX (Kyverna Therapeutics)|Prakiraan bathi perusahaan Tiziana Life Sciences (TLSA)|Cabaletta Bio - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Ventyx Biosciences, Inc. VTYX|Theratechnologies Inc (THTX) - Bathi sing dikarepake|Bathi forward AVTX (Avalo Therapeutics Inc.)|ELDN (Eledon Pharmaceuticals, Inc) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep agenusbio.com|Proyeksi bathi mangsa ngarep CLYM|Bathi resik mangsa ngarep ZURA|Proyeksi bathi mangsa ngarep ATYR (aTyr Pharmaceuticals)|Penghasilan resik sing dikarepake ADAG|ImageneBio Inc - Proyeksi bathi mangsa ngarep|STTK (shattucklabs.com) - Prakiraan bathi resik|EQ: Proyeksi bathi mangsa ngarep|Connect Biopharma Holdings (CNTB) - Proyeksi bathi mangsa ngarep|IMUX (immunic-therapeutics.com) - Proyeksi bathi mangsa ngarep|ATRA (Atara Biotherapeutics) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep IFRX|Proyeksi bathi mangsa ngarep X4 Pharmaceuticals, Inc (XFOR)|Proyeksi bathi mangsa ngarep ACET (Adicet Bio Inc.)|CELU (Celularity Corp) - Bathi forward|INmune Bio Corp - Proyeksi bathi mangsa ngarep|BRNS - Proyeksi bathi mangsa ngarep|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|SABS (sabbiotherapeutics.com) - Bathi sing dikarepake|Bathi sing dikarepake Akari Therapeutics|Bathi sing dikarepake ENLV|Bathi sing dikarepake Q32 Bio Inc (QTTB)|GOVX (GeoVax Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep EDSA (Edesa Biotech Corp)|IBIO: Prakiraan bathi resik|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep